EngCathy Vanderbilt-Ingram Cancer CenterUnited States

Professor of Medicine, Hematology and Oncology, is the David H. Johnson Endowed Chair of Surgical and Medical Oncology, VICC Associate Director, Strategic Relations and Research Partnerships, Co-Director of GI Oncology and the Co-Leader of the Gastrointestinal Cancer Research Program, and the Executive Director of the Young Adults Cancers Program at Vanderbilt-Ingram Cancer Center. She currently sits on the Board of Directors for the national patient advocacy group, Fight Colorectal Cancer. She is a highly sought mentor and served on the Vanderbilt-Ingram Mentorship Council and is currently a mentor on the T-32 grant and serves as a Professional Development Mentor. She was the Director of the Developmental Research Program for the GI SPORE. She is also a Fellow of the Executive Leadership in Academic Medicine (ELAM), Class of 2022. She continues to assume leadership positions devoted to development of phase I-III clinical trials using novel therapeutics for biomarker discovery and enhanced drug utilization in colorectal, appendiceal and anal cancer. She was awarded the VUMC Biomedical Scientific Impact Award in 2023. Nationally, Dr. Eng has also been highly active serving on ASCO, ECOG, and SWOG. She is currently for a 2nd term as the co-Chair of the NCI GI Steering Committee.